Luz PM, Morris BL, Grinsztejn B, Freedberg KA, Veloso VG, Walensky RP, Losina E, Nakamura YM, Girouard MP, Sax PE, Struchiner CJ, Paltiel AD. (2015). Cost-effectiveness of genotype testing for primary resistance in Brazil. J Acquir Immune Defic Syndr, 68(2):152-61.
Cambou MC, Luz PM, Lake JE, Levi JE, Coutinho JR, de Andrade A, Heinke T, Derrico M, Veloso VG, Friedman RK, Grinsztejn B. (2015). Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil. AIDS Patient Care STDS, 29(1):4-12.
Luz PM, Grinsztejn B, Velasque L, Pacheco AG, Veloso VG, Moore RD, Struchiner CJ. (2014). Long-term CD4+ cell count in response to combination antiretroviral therapy. PLoS One, 9(4):e93039.
Martin DA, Luz PM, Lake JE, Clark JL, Veloso VG, Moreira RI, Cardoso SW, Klausner JD, Grinsztejn B. (2014). Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011. BMC Infect Dis, 14:322.
Luz PM, Vanni T, Medlock J, Paltiel AD, Galvani AP. (2011). Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet, 377(9778):1673-80.